IST:ECILC
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. · IST · Healthcare · TRY · FY for 2025
Figures on this page computed 2026-11-08 09:51 UTC
Last close
n/aTRY
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
16.2xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- computed
- Computed from the filing for 2025
-0.5%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
21.2%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
19.1%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
0.05Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
4.0%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- computed
What it pays out is the furthest below its sector's middle: 0.44 against 0.44 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales3.03x
Its own average over 10 years, 3.25B.
- Profit1.76x
Its own average over 10 years, 1.18B.
- Free cash flow3.37x
Its own average over 10 years, 557.9M.
- Debt2.61x
Its own average over 10 years, 1.21B.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at 3.37 times.
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2016-12-31 | 100.0 | 100.0 | 100.0 |
| 2017-12-31 | 42.3 | 79.1 | 101.5 |
| 2018-12-31 | 49.0 | 129.9 | 101.5 |
| 2019-12-31 | 62.1 | 88.1 | 101.5 |
| 2020-12-31 | 64.4 | 174.3 | 101.5 |
| 2021-12-31 | 78.1 | 408.6 | 101.5 |
| 2022-12-31 | 129.6 | 2,260.7 | 101.5 |
| 2023-12-31 | 458.7 | 1,482.6 | 101.5 |
| 2024-12-31 | 620.6 | 553.9 | 101.5 |
| 2025-12-31 | 698.8 | 1,130.3 | 101.5 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- TRY
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- TRY
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- TRY
Figures behind the shape
Growth
61.1%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate61.1%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- computed
Five-year EPS growth rate45.4%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- computed
One-year change in net income104.1%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- computed
Returns on capital
-0.5%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capital-0.5%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity3.4%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets2.8%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
Margins
28.5%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin28.5%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin-4.3%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin21.2%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin19.1%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
Price
16.2xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings16.2x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- computed
- Computed from the filing for 2025
Price to book0.6x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDA63.7x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio3.4x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
Safety
0.05safer is higher, placed against 3,227 companies as of 2026-11-07
Debt to equity0.05
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio2.01
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coveragen/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score2.30
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
What it pays out
4.0%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-07
Dividend yield4.0%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- computed
Payout ratio65.3%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio1.4x
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TRY
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.